101 related articles for article (PubMed ID: 9313984)
1. DNA content and p53 protein expression in ductal breast cancer.
Ioakim-Liossi A; Karakitsos P; Markopoulos C; Aroni K; Delivelioti K; Gogas J; Kyrkou K
Cytopathology; 1997 Oct; 8(5):322-7. PubMed ID: 9313984
[TBL] [Abstract][Full Text] [Related]
2. DNA ploidy and pS2 protein expression in breast cancer.
Ioakim-Liossi A; Karakitsos P; Aroni K; Markopoulos C; Delivelioti K; Gogas J; Kyrkou K
Cytopathology; 1997 Jun; 8(3):171-6. PubMed ID: 9202892
[TBL] [Abstract][Full Text] [Related]
3. p53 protein expression and proliferative activity in ductal breast carcinomas.
Ioakim-Liossi A; Safioleas M; Karakitsos P; Athanassiadou P; Athanassiades P; Gogas J; Nakopoulou L
Cytopathology; 2000 Aug; 11(4):255-61. PubMed ID: 10983725
[TBL] [Abstract][Full Text] [Related]
4. Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis.
André S; Pinto AE; Laranjeira C; Quaresma M; Soares J
Pathobiology; 2007; 74(6):323-7. PubMed ID: 18087196
[TBL] [Abstract][Full Text] [Related]
5. p53 protein expression in benign and malignant breast lesions.
Ioakim-Liossi A; Markopoulos C; Karakitsos P; Safioleas M; Gogas J; Vaiopoulos G
Acta Cytol; 1998; 42(4):918-22. PubMed ID: 9684577
[TBL] [Abstract][Full Text] [Related]
6. p53 gene alteration and protein expression in Iranian women with infiltrative ductal breast carcinoma.
Pezeshki AM; Farjadian S; Talei A; Vasei M; Gharesi-Fard B; Doroudchi M; Ghaderi A
Cancer Lett; 2001 Aug; 169(1):69-75. PubMed ID: 11410327
[TBL] [Abstract][Full Text] [Related]
7. Correlations in survivin expression with the expression of p53 and bcl-2 in invasive ductal carcinoma of the breast.
Al-Joudi FS; Iskandar ZA; Imran AK
Southeast Asian J Trop Med Public Health; 2007 Sep; 38(5):904-10. PubMed ID: 18041310
[TBL] [Abstract][Full Text] [Related]
8. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
Geradts J; Ingram CD
Mod Pathol; 2000 Sep; 13(9):945-53. PubMed ID: 11007034
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclin Ds in relation to p53 status in human breast carcinomas.
Bukholm IK; Berner JM; Nesland JM; Børresen-Dale AL
Virchows Arch; 1998 Sep; 433(3):223-8. PubMed ID: 9769125
[TBL] [Abstract][Full Text] [Related]
10. Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein.
Leal CB; Schmitt FC; Bento MJ; Maia NC; Lopes CS
Cancer; 1995 Apr; 75(8):2123-31. PubMed ID: 7697603
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy and vimentin expression in primary breast cancer.
Ioakim-Liossi A; Karakitsos P; Markopoulos C; Aroni K; Gogas J; Kyrkou K
Cytopathology; 1995 Oct; 6(5):325-30. PubMed ID: 8785370
[TBL] [Abstract][Full Text] [Related]
12. Histological classification of invasive ductal carcinoma and the biological parameters in breast cancer.
Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
Breast Cancer; 2003; 10(2):149-52. PubMed ID: 12736568
[TBL] [Abstract][Full Text] [Related]
13. TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
Chitemerere M; Andersen TI; Holm R; Karlsen F; Børresen AL; Nesland JM
Breast Cancer Res Treat; 1996; 41(2):103-9. PubMed ID: 8944328
[TBL] [Abstract][Full Text] [Related]
14. Introduction of the cytological grading, the nuclear area, the DNA index and the DNA histogram type in the setting up of a score for ductal breast carcinoma.
Budel V; Merle S; Gasperin P; Collet JF; De Maublanc MA; Kiss R
Anticancer Res; 1994; 14(6B):2845-51. PubMed ID: 7532932
[TBL] [Abstract][Full Text] [Related]
15. [Expression of adhesive molecule CD44v6 and p53 gene in breast cancer tissues and its relation with DNA ploidy].
Zuo WS; Wei L; Wang XW; Wang YS; Yu ZY
Ai Zheng; 2004 Nov; 23(11 Suppl):1418-22. PubMed ID: 15566648
[TBL] [Abstract][Full Text] [Related]
16. Interest of investigating p53 status in breast cancer by four different methods.
Thirion A; Rouanet P; Thezenas S; Detournay D; Grenier J; Lopez-Crapez E
Oncol Rep; 2002; 9(6):1167-72. PubMed ID: 12375013
[TBL] [Abstract][Full Text] [Related]
17. p53 protein expression and nuclear DNA content in breast intraductal proliferations.
Schmitt FC; Leal C; Lopes C
J Pathol; 1995 Jul; 176(3):233-41. PubMed ID: 7674086
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal expression of Bcl-2 and p53 in breast ductal carcinoma.
Lee WY; Jin YT; Tzeng CC
Anticancer Res; 1996; 16(5A):3007-12. PubMed ID: 8917421
[TBL] [Abstract][Full Text] [Related]
19. P53 expression in patients with malignant and benign breast diseases.
Kalogeraki A; Panayiotides J; Tamiolakis D; Tzardi M; Chaniotis V; Chalkiadakis G; Melissas J; Stiftsis D; Kanavaros P; Delides GS
Anticancer Res; 2000; 20(3A):1801-5. PubMed ID: 10928110
[TBL] [Abstract][Full Text] [Related]
20. Pleomorphic carcinoma of the breast: clinicopathological analysis of 26 cases of an unusual high-grade phenotype of ductal carcinoma.
Silver SA; Tavassoli FA
Histopathology; 2000 Jun; 36(6):505-14. PubMed ID: 10849092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
